MannKind Corp. (MNKD)
2.745
-0.02
(-0.90%)
USD |
NASDAQ |
Apr 16, 16:00
2.745
0.00 (0.00%)
After-Hours: 18:08
MannKind Research and Development Expense (Quarterly) : 27.59M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| United Therapeutics Corp. | 139.50M |
| Amicus Therapeutics, Inc. | 23.74M |
| Keros Therapeutics, Inc. | 17.83M |
| BioMarin Pharmaceutical, Inc. | 192.41M |
| Ionis Pharmaceuticals, Inc. | 279.36M |